RIPK1 and in situ carcinoma: This is supported by recent results from our group indicating that the heterologous donor-reactive memory CD8+ T cells infiltrating heart allografts subjected to prolonged CIS produce TNF-α mediating RIPK1-dependent graft cell death that is required for CTLA-4Ig–resistant rejection (43).